Press release

One-of-a-kind solution for more streamlined workflows during implant procedures for cardiac devices

Berlin, Germany, February 4 -- BIOTRONIK SE & Co. KG, today announced the European launch of the Reliaty pacing system analyzer after CE approval and successful pre-market evaluation. The pacing system analyzer (PSA) is used during an implantation of implantable pacemakers, implantable cardioverter-defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT) systems to ensure adequate lead placement, maintenance of basic cardiac functions, and to evaluate pacing parameters for customized device programming.

“Using the Reliaty allows me to be more flexible during implant procedures. It can be set up and moved very quickly from one location to another whenever necessary”, says Dr. Richard Derksen, Cardiologist in the Rijnstate Clinic Arnhem, The Netherlands. “Reliaty streamlines the workflow of procedures with a focused set of exactly the analytics that are required intraoperatively and for which I would otherwise have to use a programming device which is bulkier and less mobile, especially in the constrained space of the cath lab.”

BIOTRONIK is the only company manufacturing a hand-held PSA such as Reliaty. The new intuitive user interface and option for connecting to a larger external screen allows for quick and easy testing when time is of the essence, supporting safe and accurate measurements. Reliaty also now features an additional test channel that allows for testing of up three implanted cardiac leads to more easily accommodate CRT cases. It is battery powered to last for more than 12 hours of service daily, and additionally offers a universal stationary power cord that can be used worldwide. The measurement data can be exported from the PSA to a memory stick or printed via Bluetooth®.

“Reliaty is yet another example of BIOTRONIK’s focus on developing optimized solutions for advanced patient management”, states Marlou Janssen, Vice President, Global Marketing and Sales, Cardiac Rhythm Management, BIOTRONIK. “Reliaty is part of a completely new external device portfolio from BIOTRONIK. Together with the new external pacemaker Reocor and the upcoming new programmer Renamic, BIOTRONIK is setting new standards in offering the highest quality portfolio of external CRM devices.”
 

 

About BIOTRONIK

As one of the world’s leading cardiovascular medical device companies, with several million implanted devices, BIOTRONIK is represented in over 100 countries with its global workforce of more than 5,600 employees. Known for having its fingers on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face and provides the best solutions for all phases of patient care, ranging from diagnosis and treatment to patient management. Quality, innovation and clinical excellence define BIOTRONIK and its growing success - and deliver confidence and peace of mind to physicians and their patients worldwide.

Upon publication, please provide us with a copy.

 

Press Release

 

Download (tif, 34 MB)

Download (tif, 137 MB)

Link to EON Business
Wire platform

For more information about Reliaty, please click here

Contact Information

Your Question or Comment